Litigation Details for In re: Palbociclib Patent Litigation (D. Del. 2019)
✉ Email this page to a colleague
In re: Palbociclib Patent Litigation (D. Del. 2019)
| Docket | ⤷ Try a Trial | Date Filed | 2019-10-02 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Patents | 6,936,612; 7,456,168 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in In re: Palbociclib Patent Litigation
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for In re: Palbociclib Patent Litigation (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-06-03 | 132 | Complaint - Amended | 5275 Patent No. 6,936,612 (“the ’612 patent”); U.S. Patent No. RE47,739 (“the ’739 patent”); and … U.S. Patent No. 7,456,168 (“the ’168 patent”). These three patents are referred to collectively herein…612 patent, and/or the validity of the ’612 patent. 48. Claim 1 of the ’612 patent recites…the ’739 patent, and/or the validity of the ’739 patent. 87. The ’739 patent claims, inter…claims of the ’168 patent, including claim 1 of the ’168 patent, and the ’168 patent has been listed | External link to document |
| 2020-07-24 | 151 | Notice of Service | Invalidity Contentions Regarding U.S. Patent Nos. RE47,739, 6,936,612, and 7,456,168 filed by Alembic Pharmacauticals…Palbociclib Patent Litigation 2 October 2019 1:19-md-02912 835 Patent - Abbreviated | External link to document |
| 2022-01-20 | 451 | Notice of Service | Claim Constructions for U.S. Pat Nos. 7, 456,168,6,936,612, and Re 47,739 filed by Synthon B.V., Synthon …Palbociclib Patent Litigation 2 October 2019 1:19-md-02912 835 Patent - Abbreviated | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
